Genome Medicine Q1 Unclaimed
BioMed Central Ltd.
United Kingdom
Genome Medicine is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 111. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 3680 €. The scope of the journal is focused on genetics, genomics, multi-omics, precision medicine, systems medicine. It has an SJR impact factor of 4,851 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 4,851.
Genome Medicine focuses its scope in these topics and keywords: cancer, cell, human, jak, microbiota, gene, genetic, mutations, approaches, sequence, ...
Type: Journal
Type of Copyright: CC BY + CC0
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
Price
3680 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
4,851
SJR Impact factor111
H Index141
Total Docs (Last Year)381
Total Docs (3 years)10000
Total Refs4480
Total Cites (3 years)370
Citable Docs (3 years)11.27
Cites/Doc (2 years)70.92
Ref/DocOther journals with similar parameters
Molecular Cell Q1
Annual Review of Plant Biology Q1
Cell Research Q1
Nature Structural & Molecular Biology Q1
Nature Protocols Q1
Compare this journals
Comments